MichaelAlexanderMederosMD

General Surgery • Los Angeles, CA

Physician

Join to view full profile

Dr. Mederos is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mederos' full profile

Already have an account?

Office
757 Westwood Plz
Surgery
Los Angeles, CA 90095
Phone+1 310-794-4315

Fax+1 310-267-0369

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Surgery, 2018 - 2024
UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Surgery, 2017 - 2018
Baylor College of MedicineClass of 2017
University of Texas - Pan AmericanBS, Biology, Summa cum laude, 2009 - 2013

Certifications & Licensure

CA State Medical License Current

Awards, Honors, & Recognition

Alpha Omega Alpha 2017

Publications & Presentations

PubMed

Oncogenic pathway signatures predict the risk of progression and recurrence in well-differentiated pancreatic neuroendocrine tumors.
Michael A Mederos, Colin M Court, Benjamin J Dipardo, Joseph R Pisegna, David W Dawson
Journal of Surgical Oncology. 2024-08-19
Neoadjuvant chemotherapy is associated with improved disease-free survival in pancreatic cancer patients undergoing pancreaticoduodenectomy with vascular resection.
Dustin L Dillon, Joon Y Park, Michael A Mederos, Young-Ji Seo, Jonathan King
Journal of Surgical Oncology. 2024-07-01
1 citations
Surgical and Endoscopic Resection of Duodenal Neuroendocrine Tumors Have Similar Disease-Specific Survival Outcome.
Sarah Mirzaie, Joon Y Park, Michael A Mederos, Mark D Girgis
Journal of Gastrointestinal Surgery. 2023-11-01

Press Mentions

Disparities in Referral to High-Volume Pancreatic Cancer Treatment Centers Impact SurvivalFebruary 14th, 2023